Propafenone — a new antiarrhythmic drug

Abstract
Propafenone is a new antiarrhythmic drug with class-I action and some additional sympathicolytic activities. Due to its pharmacokinetic properties the drug is appropriate for long-term oral treatment. Propafenone is especially successful in suppressing ventricular arrhythmias and in preventing tachycardias in patients with WPW syndrome. So far, final conclusions concerning the side effects cannot be drawn.

This publication has 0 references indexed in Scilit: